Literature DB >> 9435184

Discriminative stimulus effects of 8-hydroxy-2-(di-n-propylamino)tetralin in pigeons and rats: species similarities and differences.

M S Kleven1, W Koek.   

Abstract

In this study we examined the effects of 5-HT1A ligands in rats trained to discriminate 0.16 mg/kg i.p. 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) from saline in a two-lever, fixed ratio (FR)10 schedule of food reinforcement, and in pigeons trained to discriminate 0.31 mg/kg i.m. 8-OH-DPAT from saline in a two-key, FR30 schedule of food reinforcement. In both species, 8-OH-DPAT and a variety of structurally unrelated 5-HT1A ligands occasioned dose-related, relatively high levels of drug-appropriate selection (i.e. > or = 67%). A significant positive correlation was found between estimated ED50 values in both species (r = 0.84, P < .001). Further, 5-HT1A antagonists, NAN-190, penbutolol, (-)-pindolol, tertatolol and WAY-100635, produced dose-related decreases in 8-OH-DPAT-appropriate selection, and their potencies for antagonism in rats and pigeons were highly correlated (r = 0.96, P < .01). The potency of WAY 100635 in rats and pigeons was quantified by Schild analysis (apparent in vivo pA2 values: 7.8 vs. 8.3, rat vs. pigeon respectively). Although most 5-HT1A agonists produced similar 8-OH-DPAT-like discriminative stimulus effects in both species, two compounds, lisuride and eltoprazine, occasioned high levels of drug-appropriate selection in pigeons, but not in rats. In contrast, idazoxan, yohimbine, LEK 8804 and BMY 7378 produced greater effects in rats. Among this latter group of compounds, only BMY 7378 blocked the discriminative stimulus effects of 8-OH-DPAT in pigeons, which suggested that intermediate levels of drug-appropriate selection observed with the remaining compounds are not necessarily the result of low intrinsic activity. Overall, these results demonstrate similarities in the discriminative stimulus effects of 8-OH-DPAT in rats and pigeons despite different training conditions (e.g., training dose and route of administration). Even so, the finding that some 5-HT1A ligands did not produce similar effects in rats and pigeons illustrates the need to examine possible 8-OH-DPAT-like discriminative stimulus effects of compounds in both species.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435184

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Potential serotonin 5-HT(1A) and dopamine D(4) receptor modulation of the discriminative stimulus effects of amphetamine in rats.

Authors:  Danuta Marona-Lewicka; David E Nichols
Journal:  Behav Pharmacol       Date:  2011-09       Impact factor: 2.293

2.  Modification of the behavioral effects of morphine in rats by serotonin 5-HT₁A and 5-HT₂A receptor agonists: antinociception, drug discrimination, and locomotor activity.

Authors:  Jun-Xu Li; Aparna P Shah; Sunny K Patel; Kenner C Rice; Charles P France
Journal:  Psychopharmacology (Berl)       Date:  2012-09-20       Impact factor: 4.530

3.  The rise (and fall?) of drug discrimination research.

Authors:  Lance R McMahon
Journal:  Drug Alcohol Depend       Date:  2015-06-01       Impact factor: 4.492

4.  Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.

Authors:  Jillian H Broadbear; Ronan Y Depoortere; Kristina Vacy; David Ralph; Brendan J Tunstall; Adrian Newman-Tancredi
Journal:  Behav Pharmacol       Date:  2021-12-01       Impact factor: 2.293

5.  Differential effects of serotonin 5-HT1A receptor agonists on the discriminative stimulus effects of the 5-HT2A receptor agonist 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rats and rhesus monkeys.

Authors:  Jun-Xu Li; Wouter Koek; Kenner C Rice; Charles P France
Journal:  J Pharmacol Exp Ther       Date:  2010-01-06       Impact factor: 4.030

6.  Evaluation of the phencyclidine-like discriminative stimulus effects of novel NMDA channel blockers in rats.

Authors:  Katherine L Nicholson; Robert L Balster
Journal:  Psychopharmacology (Berl)       Date:  2003-07-08       Impact factor: 4.530

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.